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Summary
Mitochondria-derived vesicles (MDVs) have been shown to
transport cargo from the mitochondria to the peroxisomes
[1]. Mitochondria and peroxisomes share common functions
in the oxidation of fatty acids and the reduction of damaging
peroxides [2, 3]. Their biogenesis is also linked through both
the activation of master transcription factors such as PGC-
1a [4, 5] and the common use of fission machinery, including
DRP1, Mff, and hFis1 [6–9]. We have previously shown that
MDVs are formed independently of the known mitochondrial
fission GTPase Drp1 and are enriched for a mitochondrial
small ubiquitin-like modifier (SUMO) E3 ligase called
MAPL (mitochondrial-anchored protein ligase) [1]. Here, we
demonstrate that the retromer complex, a known component
of vesicle transport from the endosome to the Golgi appa-
ratus [10–13], regulates the transport of MAPL from mito-
chondria to peroxisomes. An unbiased screen shows that
Vps35 and Vps26 are found in complex with MAPL, and
confocal imaging reveals Vps35 recruitment to mitochon-
drial vesicles. Silencing of Vps35 or Vps26A leads to a signif-
icant reduction in the delivery of MAPL to peroxisomes,
placing the retromer within a novel intracellular trafficking
route and providing insight into the formation of MAPL-
positive MDVs.
Results
In the search for mechanisms that regulate mitochondrial fis-
sion, we recently uncovered MAPL (mitochondrial-anchored
protein ligase) as a novel mitochondrial small ubiquitin-like
modifier (SUMO) E3 ligase that positively regulates the mito-
chondrial fission GTPase Drp1 [1, 14]. Upon silencing of Drp1
to block mitochondrial fragmentation, the resulting fused mito-
chondrial reticulum allowed us to visualize the presence of
small vesicular profiles that carried selected cargo. One popu-
lation of these vesicles carried MAPL but lacked the outer
membrane marker Tom20 [1]. These structures were then
shown to fuse with a subpopulation of peroxisomes, providing
the first evidence for a novel vesicular transport route between
these organelles. In an effort to better understand the function
of MAPL in mitochondria and peroxisomes, we searched for
interacting partners via an affinity chromatography approach.
MAPL is a mitochondrial membrane protein containing two
hydrophobic regions that separate two functional domains,
a BAM (beside a membrane) domain of unknown function
within the intermembrane space [15] and a RING-finger motif
exposed to the cytosol. We have previously demonstrated
that the cytosolic RING domain is an active SUMO E3 ligase*Correspondence: hmcbride@ottawaheart.ca[14]. In order to identify cytosolic binding partners and poten-
tial SUMO substrates for MAPL, we fused the C-terminal cyto-
solic domain of MAPL, which includes the RING-finger motif,
to glutathione S-transferase (GST) and incubated the immobi-
lized protein with cytosolic extracts derived from human
placenta. Coomassie-stained proteins that specifically bound
GST:MAPL(257–352) were then analyzed by mass spectrometry
(Figures 1A and 1B). In one of the bands, we identified eight
peptides matching a component of the mammalian retromer
complex Vps35 (Figure 1B). This interacting partner was of
interest because Vps35, in addition to the other components
of the retromer complex, Vps26 and Vps29, is known to be
involved in the selection of cargo into vesicles [16–18],
a process that we had also observed in mitochondrial vesicle
formation. Western blot analysis confirmed the specificity of
Vps35 binding to the purified RING domain of MAPL
(Figure 1C). Although we did not identify peptides derived
from Vps26A or Vps29 in the mass spectrometry analysis, we
confirmed the binding of Vps26A to the MAPL:RING domain
by western blot analysis, consistent with the retromer func-
tioning as a heterotrimeric complex (Figure 1C).
We then tested whether MAPL and Vps35 might interact in
transfected cells. MAPL:Flag and Vps35:YFP were cotrans-
fected in HEK293T cells, and MAPL:Flag was immunoprecipi-
tated using a-Flag agarose beads. Immunodetection with a-FP
antibodies revealed that Vps35:YFP coprecipitates with
MAPL:Flag (Figure 1D, right). In addition to coprecipitating
with transfected proteins, the endogenous Vps35 was also
seen to coprecipitate with MAPL:Flag from transfected HeLa
cells (Figure 1E). Interestingly, the interaction with Vps35 was
unaffected upon the inactivation of the RING domain using
an H319L mutation (Figure 1E). This was not unexpected,
because the transport of MAPL to the peroxisomes does not
depend on a functional SUMO E3 ligase activity, suggesting
that the incorporation into vesicles is not directly related to
its catalytic activity [1]. Finally, to further validate this interac-
tion, we performed crosslinking studies on postnuclear super-
natants to examine the interaction of endogenous MAPL with
Vps35 and Vps26A. The addition of bis-maleimidohexane
(BMH) to postnuclear supernatant led to the appearance of
a high-molecular-weight crosslinked product immunoreactive
for both Vps26A and Vps35 (+BMH input lanes, visualized with
a 4%–20% acrylamide gel; Figures 1F and 1G). Importantly,
these high-molecular-weight species coimmunoprecipitated
with endogenous MAPL, indicating that MAPL binds to the
Vps26A/Vps35 retromer complex in HeLa cells (visualized
with an 8% gel; arrows in Figures 1F and 1G).
The retromer complex has not been previously determined
to be localized to mitochondria, so we next tested whether
Vps35 may be recruited to mitochondria. Overexpressed
Vps35:YFP is mainly cytosolic with a few punctate structures,
consistent with its established endosomal localization [17].
However, when CFP:MAPL was coexpressed with Vps35:YFP,
a fraction of the Vps35:YFP was recruited to MAPL-positive
vesicular structures (Figure 2A, white circle) or to subdomains
along the mitochondria (Figure 2A, white arrows). To confirm
the colocalization of Vps35:YFP and CFP:MAPL, we used
time-lapse imaging to test whether the two structures move
Figure 1. MAPL and Vps35 Are in a Complex
(A) Five milligrams of bacterially purified
GST:MAPL-RING or GST alone was incubated
with 50 mg of human placenta cytosol. The
RING domain and binding partners were subse-
quently eluted upon cleavage by thrombin.
After staining with Coomassie blue, bands were
excised and sent for mass spectrometry anal-
ysis.
(B) Liquid chromatography-tandem mass spec-
trometry analysis identified eight peptides
matching Vps35. Mascot scores and probabili-
ties are indicated.
(C) Fifty micrograms of human placental postmi-
tochondrial supernatant, along with the elutions
from the affinity column, was probed with
a-Vps35 and a-Vps26A antibodies, as indicated.
(D) Vps35:YFP and MAPL:Flag were cotrans-
fected into HEK293T cells for 16 hr before
cells were solubilized and immunoprecipitated
with a-Flag agarose beads. The western blots
were decorated with a-FP to detect Vps35 and
a-Flag to visualize MAPL. The arrow indicates
Vps35:YFP.
(E) MAPL:Flag or MAPL(H319L):Flag was trans-
fected into HeLa cells and immunoprecipitated
with a-Flag agarose beads. The coimmunopreci-
pitation of endogenous Vps35 was revealed with
a-Vps35 antibodies.
(F and G) Postnuclear supernatants of HeLa cells
were collected and then incubated with or
without a 1 mM concentration of the bis-maleimi-
dohexane crosslinker (BMH) as indicated. After
the crosslinker was quenched with dithiothreitol
and the extracts were solubilized, endogenous
MAPL was immunoprecipitated from the BMH-
treated samples. Inputs without crosslinker
were analyzed by SDS-PAGE using a 4%–20%
acrylamide gel, whereas the inputs and immuno-
precipitations with crosslinker were analyzed by
8% SDS-PAGE. Western blot analysis was per-
formed to reveal Vps26A (F) or Vps35 (G). The
arrow indicates the crosslinked products.
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able online). In the acquired video, a tubulated MAPL-positive
structure labeled with Vps35:YFP at the tip is seen to pinch off
and move upward through the cell. We then quantified the
number of cells in which Vps35:YFP was visibly recruited to
mitochondria via confocal microscopy. The data show that
Vps35:YFP was recruited to mitochondria in 10% of cells
transfected with OCT:CFP as a mitochondrial marker. This
recruitment was increased in cells transfected with
CFP:MAPL, where 25% of the cells contained mitochondria
labeled with Vps35:YFP (p < 0.05, Student’s t test). This indi-
cates that the recruitment of Vps35:YFP to the mitochondria
is enhanced upon MAPL expression, consistent with a func-
tional interaction (Figure 2C). Finally, we further confirmed
the presence of endogenous Vps35 on mitochondria by both
immunofluorescence and electron microscopy (EM) (Figures
2D and 2E). The specificity of the Vps35 antibody was demon-
strated with RNA interference (RNAi)-treated cells silenced for
Vps35, where the staining was reduced to background
(Figure S1). As observed by both EM and fluorescence, the
Vps35 antibody labeled numerous structures within the cell,
consistent with previous studies (Figures 2D and 2E). Inaddition to this label, we also observed enrichment for endog-
enous Vps35, by both gold and immunofluorescence, on mito-
chondria, in agreement with the overexpression studies.
Because MAPL overexpression increased the recruitment of
Vps35 to the mitochondria, we next wanted to confirm endog-
enous Vps35 recruitment to mitochondria using biochemical
fractionation and to test whether its recruitment required the
presence of MAPL (Figure 3A). We used small interfering
RNA (siRNA) to transiently knock down MAPL (or nontargeted
siRNA) in HeLa cells (Figure 3A) for 60 hr. Mitochondria from
these two cell lines were fractionated using differential centri-
fugation and further purified using a percoll gradient. The
whole-cell extract (WCE), cytosolic, and mitochondrial frac-
tions were probed for a number of markers. The purity of the
mitochondrial fractions was demonstrated by the enrichment
of mitochondrial markers VDAC and MAPL and the absence
of markers for the early endosomes, Golgi apparatus, and
cytosol. Consistent with our previous results, endogenous
Vps35 was present in the mitochondrial fractions. The retro-
mer complex has been associated with retrograde transport
of cargo from Rab5-positive early endosomes [11, 18–20], so
the absence of EEA1 in the fractions indicates that the
Figure 2. Vps35 Is Recruited to Emerging Mito-
chondria-Derived Vesicles Enriched for MAPL
(A) CFP:MAPL and Vps35:YFP were cotrans-
fected into HeLa cells for 16 hr. Representative
confocal images acquired to visualize the trans-
fected proteins are shown. White circles highlight
Vps35:YFP recruitment to MAPL-positive vesic-
ular structures, and white arrows indicate
Vps35:YFP recruitment to the mitochondria.
Scale bar represents 20 mm.
(B) Confocal time-lapse imaging of CFP:MAPL
and Vps35:YFP transfected into HeLa cells
shows the recruitment of Vps35:YFP to the
CFP:MAPL-labeled mitochondria and the move-
ment of the vesicle through the cell. Scale bar
represents 1 mm. See also Movie S1.
(C) Quantification of the recruitment of
Vps35:YFP to the mitochondria. Cells were trans-
fected with OCT:CFP or CFP:MAPL and Vps35:
YFP. The number of cells with Vps35:YFP-posi-
tive structures colocalizing with the mitochon-
drial marker was quantified. Sixty cells were
analyzed from three independent experiments.
Data are presented as the mean and standard
error of the mean.
(D) To observe endogenous Vps35 recruitment to
mitochondria, we transfected HeLa cells with
MAPL:YFP and fixed and stained them for
endogenous Vps35. The white arrow indicates
the recruitment of Vps35:YFP to the mitochon-
dria. Scale bar represents 20 mm.
(E) Cells expressing CFP-MAPL were immunola-
beled with anti-Vps35 for analysis by electron
microscopy. Panel (i) shows the global decora-
tion of Vps35 on endocytic structures. In panels
(ii) and (iii), arrowheads indicate the specific label
of Vps35 associated with mitochondria (M). Addi-
tional structures are seen with strong Vps35
labeling as well. Scale bars represent 500 nm.
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nating early endosomes. We did observe the presence of
LAMP1, a lysosomal marker, cofractionating within our mito-
chondrial preparations. However, the extent of lysosomal
proteins within these fractions was variable between the
three independent runs (Figure S2), whereas the levels of
Vps35 were unchanged (Figure 3B). This indicates that
the Vps35 signal in the mitochondrial fraction corresponds to
Vps35 recruited to mitochondria, and not to the contaminating
late endosomes and/or lysosomes. Importantly, the silencing
of MAPL did not affect the level of Vps35 recruitment to mito-
chondria (Figure 3B), suggesting that other mitochondrial
binding partners must exist for Vps35.Because MAPL is present on vesicular
profiles and Vps35 is part of the retromer
complex, we considered that Vps35 may
be required for the formation of MAPL-
containing mitochondria-derived vesi-
cles (MDVs). To track the fate of newly
synthesized MAPL en route to the
peroxisomes, we employed an inducible
Tet-On system to study YFP:MAPL
MDV transport. Vps35 was silenced
for 48 hr in MCF7 cells expressing a
doxycycline-responsive transactivator.
The cells were then transiently trans-
fected with the inducible plasmidencoding YFP:MAPL. The cells were treated with doxycycline
for 3 hr to induce expression. This pulse of new synthesis was
chased forward by the addition of cycloheximide for another
2 hr. The peroxisome delivery of YFP:MAPL was then analyzed
by immunofluorescence (Figure 4A). We quantified YFP:
MAPL-positive peroxisomes stained with the integral mem-
brane protein Pmp70 in cells silenced for Vps35 relative
to control cells (Figure 4B). The data show that there is
a 50% reduction in the number of YFP:MAPL peroxisomes
per cell in the cells treated with Vps35 RNAi compared to the
cells treated with nontargeted RNAi, indicating that the down-
regulation of Vps35 leads to a significant reduction in the
rates of YFP:MAPL transport to peroxisomes (Student’s
Figure 3. Vps35 Recruitment to Mitochondria Is MAPL Independent
(A) Whole-cell extract (WCE), cytosolic, and percoll-purified mitochondrial
fractions from 453 106 HeLa cells treated with either siRNA directed against
MAPL or a nontargeted (NT) siRNA control were separated by SDS-PAGE.
Western blots were stained with a-Vps35, a-MAPL, a-giantin (Golgi marker),
a-EEA1 (endosomal marker), a-calnexin (ER marker), a-tubulin (cytosolic
marker), and a-VDAC (mitochondrial marker).
(B) Quantification of the amount of mitochondrial Vps35 in cells treated with
nontargeted RNAi or with RNAi directed against MAPL. The data were quan-
tified from three independent experiments and are presented as the mean
and the standard error of the mean.
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Vps35 leads to the destabilization of the other components
of the retromer complex [11, 19, 21]. We confirmed that the
downregulation of Vps35 leads to reduced levels of Vps26A
and that the loss of Vps26A leads to a partial destabilization
of Vps35 by western blot analysis, with MAPL and Hsp70 levels
unaffected (Figure S3A). Consistent with these results, the loss
of Vps26A also led to a significant reduction in the number
of YFP:MAPL-positive peroxisomes per cell (Student’s t test,
p < 0.05) (Figure S3B).
Finally, we have shown previously that different populations
of MDVs are present in cultured cells. To determine whether
the retromer may function in multiple MDV transport routes,
we quantified the number of Tom20-positive, cytochrome
c-negative vesicles per cell in the presence or absence of
Vps35 (Figure 4C). Interestingly, the number of Tom20-positive
MDVs was increased upon the downregulation of Vps35
(Figure 4C), indicating that the retromer complex is not
required for the generation of Tom20-containing MDVs. It is
currently unclear why Tom20 MDVs are increased upon
Vps35 silencing; one possibility is that the loss of the mito-
chondrial-to-peroxisomal transport may lead to a metabolic
stress that triggers the formation of Tom20 MDVs.
Discussion
With the identification of MDVs, we have expanded the mech-
anisms by which the mitochondria communicate with the
peroxisomes [1, 15]. This transport pathway has not yet been
functionally characterized; however, our data show that the
delivery of MAPL is specific to only a subpopulation of perox-
isomes in the cell [1] (Figure 4). We are currently exploring
potential functions in peroxisome biogenesis, fatty acid catab-
olism, and potential signaling pathways that could relate to the
SUMOylation activity of MAPL on the peroxisomes [15].
However, an obvious first step in our ability to examine the
functional impact of mitochondria on peroxisome transportis the identification of the machinery that governs this event.
In an unbiased screen for MAPL-interacting proteins, we
have identified the retromer complex as a candidate coat
protein to facilitate MDV formation. Experiments presented
here demonstrate that Vps35, Vps26A, and MAPL are found
in a complex (Figure 1), and both EM and confocal imaging
techniques have confirmed the presence of endogenous
Vps35 in association with subdomains of the mitochondria
(Figure 2). Although MAPL is a SUMO E3 ligase [14], its enzy-
matic activity does not appear to be requisite for efficient
Vps35 binding to MAPL. Functionally, we have demonstrated
that silencing Vps35 or Vps26A inhibits the formation of
MAPL MDVs and their subsequent delivery of MAPL to the
peroxisome. Importantly, we had previously been unable to
modulate vesicle delivery to peroxisomes [1], so the inhibition
of this transport route is an important further validation of
the pathway.
The function of the retromer complex on mitochondria might
suggest the presence of mitochondrial sorting nexins, clathrin,
and related chaperones such as RME-8 and Rab GTPases that
could also participate in retromer-dependent MDV transport
[20–22]. Although a role for these types of proteins at the mito-
chondria has not yet been widely considered, our data may be
consistent with emerging studies suggesting that the retromer
complex may function in multiple intracellular transport path-
ways. It has been proposed, for example, that the combinato-
rial use of paralogs of the retromer components and different
adaptor sorting nexin proteins may help to explain a wide
range of cargo selectivity and localizations of this complex
[13, 23–25]. It is not unprecedented for the mitochondria to
utilize structural adaptors and enzymes in common with the
endocytic and biosynthetic pathways [26]. Proteins such as
synaptojanin 2A [27], endophilin B1 [28, 29], Rab32 [30],
WAVE-1 [31], and a mitochondrial phospholipase D [32]
are known to affect mitochondrial function and dynamics.
Together, these data demonstrate that the transport and
morphology of mitochondrial membranes share many features
with the more established pathways in cell biology. With the
identification of some of the machinery required for MDV trans-
port to peroxisomes, we have a tool to help us dissect this
pathway and further characterize the regulatory machinery.Supplemental Information
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Figure 4. Vps35 Is Required for the Formation of MAPL Mitochondria-Derived Vesicles
(A) Stable MCF7 cells expressing the Tet-On advanced plasmid treated with nontargeted (NT) RNAi or Vps35 RNAi for 48 hr were then transfected with the
inducible YFP:MAPL plasmid. YFP:MAPL expression was induced with doxycycline for 3 hr, followed by a cycloheximide chase for 2 hr. Cells were then fixed
and stained for peroxisomal Pmp70 and the mitochondrial cytochrome c marker, and confocal images were obtained, as indicated. White circles indicate
the colocalization of MAPL with a subpopulation of peroxisomes, which are reduced upon Vps35 silencing.
(B) Quantifications of the number of YFP:MAPL-positive peroxisomes per cell in each condition were obtained from 52–54 cells from three independent
experiments. Data are presented as the mean and standard error of the mean. To confirm efficient Vps35 silencing in these experiments, we probed
whole-cell extracts with a-Vps35 and a-Hsp70 (loading control) as indicated.
(C) HeLa cells were treated with nontargeted (NT) RNAi or Vps35 RNAi for 72 hr, and the number of Tom20-positive, cytochrome c-negative mitochondria-
derived vesicles (MDVs) per cell was counted. Sixty cells from three independent experiments were analyzed. Data are presented as the mean and standard
error of the mean. To confirm efficient Vps35 silencing in these experiments, we probed whole-cell extracts with a-Vps35 and a-Hsp70 (loading control) as
indicated.
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